Skip to content

Released May 8, 2018, after the close

10-Q filed May 8, 2018, 38 days after period end · 0001162194-18-000055

Q1 2018 · 10-Q
Revenue$25.25M−1.1% vs Q1 2017−9.0% vs Q4 2017
Net Income-$13.25MN/M vs Q1 2017N/M vs Q4 2017
EPS Diluted-$0.34N/M vs Q1 2017N/M vs Q4 2017
Gross Profit$13,428,000—
Operating Income-$12,633,000N/M
Operating Cash Flow-$16,176,000N/M
Free Cash Flowderived-$16,253,000N/M
Margins · derived
Gross margin53.2%
Operating margin-50.0%+18.6 pt vs Q1 2017
Net margin-52.5%+14.9 pt vs Q1 2017

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2018Q1 2017Q1 2016Q1 2015
Revenue$25.25M$25.53M$29.00M$26.73M
Net Income-$13.25M-$17.20M-$19.88M-$15.93M
EPS Diluted-$0.34-$0.59-$0.69-$0.56

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR